logo

Search

Login | Create Account

respiratory


Categories

Allergy Asthma COPD Cystic fibrosis End-of-life care ILD Infections Infectious diseases Interventional procedures Lung cancer Medicines Medicopolitical Podcast Public health Research Sleep

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo
Medicopolitical

Respiratory groups slam Big Tobacco plan to pay pharmacies for vaping promotion

Respiratory professional groups and doctor organisations have slammed reports that Big Tobacco will enter into commercial agreements with community pharmacies to promote the sale of nicotine e-cigarettes, ostensibly for smoking cessation. The multinational tobacco company Philip Morris is reportedly offering cash incentives to Australian pharmacists in return for spruiking one of...

Update & debate — the changing face of COPD

Join your colleagues for dinner in Melbourne or watch online as a team of expert respiratory physicians discusses best practice and tackles a hot topic in COPD management. Hosted by Professor Christine McDonald Director, Dept of Respiratory & Sleep Medicine; Medical Director, Institute for Breathing & Sleep, Austin...

Cystic fibrosis

CFTR modulator trial in infants paves the way for earlier access: Australian expert

A trial in children under two years of age with cystic fibrosis will pave the way to earlier access to CFTR modulation and maybe to modifying the course of disease for up to 50% of very young children with CF, an Australian expert says. Results from...

Research

Dyspnoea’s high morbidity and mortality burden in ambulance callouts

Patients with dyspnoea transported by ambulance to hospital have a high morbidity and mortality from respiratory diseases , a Victorian study shows. One in every seven Australian patients who call for an ambulance are exhibiting breathlessness when crews arrive, the analysis...

Patients with dyspnoea transported by ambulance to hospital have a high morbidity and mortality from respiratory diseases , a Victorian...


Asthma

Age 40 the watershed for addressing asthma exacerbation burden 

Asthma exacerbations are associated with faster lung function decline, particularly in younger patients, the largest study of its kind confirms. The findings highlight the “potential value” of addressing exacerbation burden when patients are still in the growth...

Asthma exacerbations are associated with faster lung function decline, particularly in younger patients, the largest study of its...


Asthma

PAL phenotype a treatable trait even in mild asthma: ATLANTIS

Increasing treatment intensity should be considered in patients with milder asthma and the persistent airflow limitation (PAL) phenotype, a new analysis of the landmark ATLANTIS study suggests. The PAL phenotype is present in people living with asthma across the spectrum of...

Increasing treatment intensity should be considered in patients with milder asthma and the persistent airflow limitation (PAL) phenotype, a new...


Cancel